Merck & Co. (NYSE: MRK) on Thursday shared positive second RSV season findings from the Phase 3 SMART trial. The results from the SMART trial were presented at the RSVVW Conference and will be shared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results